Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 161: What congenital anomaly is produced by lithium therapy?

A. Limb shortening
B. Anencephaly
C. Heart block (Correct Answer)
D. Renal agenesis

Explanation: **Explanation:** Lithium is a primary mood stabilizer used in Bipolar Affective Disorder (BPAD). However, it is a known teratogen when administered during the first trimester of pregnancy. **Why Heart Block is the Correct Answer:** Lithium exposure in utero is classically associated with **Ebstein’s Anomaly**, a congenital cardiac defect characterized by the downward displacement of the tricuspid valve into the right ventricle ("atrialization" of the ventricle). This structural deformity often leads to tricuspid regurgitation and disruption of the cardiac conduction system, manifesting as **Heart Block** or arrhythmias (e.g., Wolff-Parkinson-White syndrome). While the absolute risk is low, the relative risk is significantly higher in lithium-exposed infants compared to the general population. **Analysis of Incorrect Options:** * **A. Limb shortening:** This is characteristic of **Thalidomide** (Phocomelia), not lithium. * **B. Anencephaly:** This neural tube defect is typically associated with **folate deficiency** or drugs like **Valproate** and Carbamazepine. * **D. Renal agenesis:** While lithium can cause nephrogenic diabetes insipidus in adults, it is not a primary cause of fetal renal agenesis (which is more commonly associated with ACE inhibitors/ARBs). **High-Yield Clinical Pearls for NEET-PG:** * **Ebstein’s Anomaly:** The most specific cardiac defect associated with Lithium. * **Monitoring:** If a pregnant woman must continue Lithium, perform a **fetal echocardiogram** at 18–20 weeks. * **L/D Ratio:** Lithium has a narrow therapeutic index (0.6–1.2 mEq/L). * **Other Teratogens:** * *Valproate:* Neural tube defects (Spina bifida). * *Phenytoin:* Fetal Hydantoin Syndrome (cleft lip/palate, digital hypoplasia). * *Warfarin:* Fetal Warfarin Syndrome (stippled epiphyses, nasal hypoplasia).

Question 162: All of the following drugs have immunosuppressive effects, EXCEPT?

A. Cyclosporine
B. Cefaclor (Correct Answer)
C. Azathioprine
D. Steroids

Explanation: **Explanation:** The core concept of this question lies in distinguishing between **immunomodulators** (drugs that modify the immune response) and **antimicrobials** (drugs that target pathogens). **1. Why Cefaclor is the Correct Answer:** Cefaclor is a **second-generation cephalosporin antibiotic**. Its mechanism of action involves inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). It is used to treat bacterial infections and has **no immunosuppressive properties**. In fact, by clearing an infection, it allows the host's natural immune system to recover from the stress of the pathogen. **2. Analysis of Incorrect Options:** * **Cyclosporine (Option A):** A potent immunosuppressant (calcineurin inhibitor). It acts by inhibiting the transcription of Interleukin-2 (IL-2), thereby preventing T-cell activation. It is a mainstay in preventing organ transplant rejection. * **Azathioprine (Option B):** A purine antimetabolite (prodrug of 6-mercaptopurine). It inhibits DNA synthesis, which suppresses the proliferation of rapidly dividing cells, particularly T and B lymphocytes. It is used in autoimmune diseases like SLE and Rheumatoid Arthritis. * **Steroids (Option D):** Glucocorticoids (e.g., Prednisolone) are broad-spectrum immunosuppressants. They inhibit the expression of multiple inflammatory cytokines (IL-1, IL-2, TNF-alpha) and induce apoptosis in lymphocytes. **Clinical Pearls for NEET-PG:** * **Cyclosporine Side Effects:** Remember the "3 H's"—**H**ypertension, **H**irsutism, and **H**yperplasia (gingival). Unlike Tacrolimus, it is more likely to cause gingival hyperplasia. * **Azathioprine Interaction:** Always check for **Allopurinol** co-administration. Allopurinol inhibits xanthine oxidase, leading to toxic levels of 6-MP and severe bone marrow suppression. * **Cefaclor Specificity:** It is often associated with a "Serum Sickness-like reaction" in children, a high-yield adverse effect for exams.

Question 163: All of the following are seen in morphine poisoning except?

A. Cyanosis
B. Pinpoint pupil
C. Hypertension (Correct Answer)
D. Respiratory depression

Explanation: ### Explanation Morphine poisoning is characterized by a classic clinical triad: **Coma, Pinpoint pupil, and Respiratory depression.** **1. Why Hypertension is the correct answer (The "Except"):** Morphine poisoning typically causes **Hypotension**, not hypertension. Morphine induces peripheral vasodilation through two primary mechanisms: direct depression of the vasomotor center in the medulla and the non-immunological release of **histamine** from mast cells. This leads to a decrease in peripheral resistance and a fall in blood pressure, which can eventually progress to circulatory shock. **2. Analysis of Incorrect Options:** * **Cyanosis:** This occurs as a secondary consequence of severe **respiratory depression**. As the rate and depth of breathing decrease, oxygen saturation drops (hypoxia), leading to a bluish discoloration of the skin and mucous membranes. * **Pinpoint Pupil (Miosis):** This is a hallmark sign caused by the stimulation of the **Edinger-Westphal nucleus** of the 3rd cranial nerve. It is a central effect; notably, even in overdose, the pupils remain reactive to light (though very small), unless severe hypoxia causes terminal pupillary dilation. * **Respiratory Depression:** Morphine directly reduces the sensitivity of the brainstem respiratory centers to carbon dioxide ($CO_2$). This is the most common cause of death in opioid overdose. **Clinical Pearls for NEET-PG:** * **Specific Antagonist:** **Naloxone** is the drug of choice for morphine poisoning (given IV). * **The "Mydriatic" Opioid:** **Pethidine (Meperidine)** is an exception; it often causes mydriasis (dilated pupils) rather than miosis due to its atropine-like (anticholinergic) action. * **Diagnostic Triad:** Always look for the combination of **miosis, respiratory depression, and altered mental status** to diagnose opioid toxicity in clinical vignettes.

Question 164: What are the earliest manifestations of chronic lead poisoning?

A. Colic and constipation
B. Encephalopathy
C. Punctate basophilia (Correct Answer)
D. Lower limb paralysis

Explanation: **Explanation:** Chronic lead poisoning (Plumbism) affects multiple organ systems, but the earliest detectable changes occur in the hematological system. **1. Why Punctate Basophilia is correct:** Punctate basophilia (also known as **Basophilic Stippling**) is considered the earliest clinical sign of lead poisoning. Lead inhibits the enzyme **1,4-pyrimidine 5’-nucleotidase**, which normally degrades ribosomal RNA in reticulocytes. The persistence of undegraded ribosomal fragments results in characteristic blue granules (stippling) within red blood cells on a peripheral smear. While not pathognomonic (it also occurs in thalassemias), it is the first laboratory manifestation to appear. **2. Why other options are incorrect:** * **Colic and Constipation:** These are common gastrointestinal manifestations (Lead Colic) but typically appear *after* hematological changes have already occurred. * **Encephalopathy:** This is a late and severe manifestation of acute or chronic toxicity, more common in children, characterized by cerebral edema and increased intracranial pressure. * **Lower limb paralysis:** Lead-induced neuropathy characteristically affects the **upper limbs** first (wrist drop due to radial nerve palsy) rather than the lower limbs. **High-Yield Clinical Pearls for NEET-PG:** * **Enzymes inhibited:** $\delta$-aminolevulinic acid dehydratase (ALAD) and Ferrochelatase (leading to increased Free Erythrocyte Protoporphyrin). * **Burtonian Line:** A bluish-purple line on the gums (lead line) due to reaction with bacterial hydrogen sulfide. * **Radiology:** "Lead lines" at the metaphyses of growing long bones in children. * **Treatment:** Chelation therapy with **Succimer** (oral, drug of choice), Calcium disodium EDTA, or British Anti-Lewisite (BAL).

Question 165: Which of the following drugs does NOT carry a definitive risk of causing clinical hemolysis in patients with G6PD deficiency?

A. Primaquine
B. Chloroquine (Correct Answer)
C. Dapsone
D. Nalidixic acid

Explanation: **Explanation** Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is an X-linked recessive disorder where RBCs lack the ability to regenerate reduced glutathione, making them highly susceptible to oxidative stress. When exposed to certain oxidizing drugs, hemoglobin precipitates into **Heinz bodies**, leading to hemolysis. **Why Chloroquine is the Correct Answer:** While Chloroquine is an antimalarial, it is considered **safe** or carries a negligible risk of hemolysis in most individuals with G6PD deficiency at standard therapeutic doses. Unlike its counterparts, it does not exert significant oxidative stress on the erythrocyte membrane. In clinical practice, it is generally administered without prior G6PD screening, unlike Primaquine. **Analysis of Incorrect Options:** * **Primaquine (Option A):** This is the classic "high-yield" trigger. It is a potent oxidizing agent that causes severe acute hemolytic anemia in G6PD-deficient patients. Screening is mandatory before starting radical cure for *P. vivax*. * **Dapsone (Option B):** A sulfone used in leprosy and PCP prophylaxis; it is a well-known inducer of oxidative hemolysis and methemoglobinemia. * **Nalidixic Acid (Option D):** An older quinolone antibiotic that is a documented trigger for hemolytic crises in deficient patients. **NEET-PG High-Yield Pearls:** * **Mnemonic for G6PD Triggers:** "**S**andwich **P**atty **I**s **N**ot **D**elicious" (**S**ulfonamides/Sulfones, **P**rimaquine/Pyridium, **I**soniazid, **N**itrofurantoin, **D**apsone). * **Other Triggers:** Fava beans (Favism), Rasburicase (absolute contraindication), and infections (most common cause). * **Diagnosis:** Peripheral smear shows **Bite cells** (degmacytes) and **Heinz bodies** (supravital staining). * **Timing:** Avoid testing G6PD levels during an acute hemolytic episode, as young reticulocytes have normal enzyme levels, leading to a false-negative result.

Question 166: Which of the following drugs are used for obesity reduction?

A. Sibutramine
B. Olestra
C. Fenfluramine
D. All of the above (Correct Answer)

Explanation: **Explanation:** The management of obesity involves various pharmacological targets, including appetite suppression and the inhibition of fat absorption. * **Sibutramine (Option A):** This is a **serotonin-norepinephrine reuptake inhibitor (SNRI)**. It acts centrally to increase satiety and elevate metabolic rate. While effective for weight loss, it has been largely withdrawn from many markets (including India and the US) due to an increased risk of non-fatal cardiovascular events like stroke and myocardial infarction. * **Olestra (Option B):** This is a **sucrose polyester** used as a non-absorbable fat substitute in foods. It has the physical properties of fat but cannot be hydrolyzed by pancreatic lipases, meaning it passes through the GI tract without being absorbed, thereby reducing caloric intake. A common side effect is "steatorrhea" or oily spotting. * **Fenfluramine (Option C):** This is an **indirect-acting sympathomimetic** that promotes the release of serotonin. It was historically used as an anorectic (often in the "Fen-Phen" combination). However, it was withdrawn due to its association with **pulmonary hypertension** and **cardiac valvular fibrosis**. Since all three agents have been utilized in the clinical management or dietary strategy for obesity reduction, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Orlistat:** Currently a first-line drug; it is a **gastric and pancreatic lipase inhibitor** that prevents dietary fat absorption. * **Lorcaserin:** A selective **5-HT2C receptor agonist** used for weight loss (recently withdrawn in some regions due to cancer risk). * **Liraglutide/Semaglutide:** **GLP-1 analogues** originally for diabetes, now highly effective for obesity by slowing gastric emptying and increasing satiety. * **Qsymia:** A fixed-dose combination of **Phentermine and Topiramate**.

Question 167: Which of the following drugs is not primarily indicated for sedation, but commonly causes sedation as a side effect?

A. Antihistamines and antidepressants
B. Phenytoin (Correct Answer)
C. Cyclosporine and macrolides
D. Amphotericin B

Explanation: **Explanation:** **Phenytoin** is the correct answer because it is primarily indicated as an **anti-epileptic drug (AED)** for the treatment of focal and generalized tonic-clonic seizures. Unlike benzodiazepines or barbiturates, its primary mechanism is the blockade of voltage-gated sodium channels, not global CNS depression. However, **sedation, ataxia, and nystagmus** are common dose-dependent side effects resulting from its depressant effect on the cerebellum and vestibular system. **Analysis of Incorrect Options:** * **Option A (Antihistamines and Antidepressants):** While these commonly cause sedation (especially 1st generation antihistamines and TCAs), they are often used specifically for their sedative properties in clinical practice (e.g., diphenhydramine for insomnia). Phenytoin's sedation is strictly an unwanted adverse effect. * **Option B (Cyclosporine and Macrolides):** These drugs are associated with neurotoxicity (tremors, seizures) and GI distress, but sedation is not a characteristic or common side effect. * **Option C (Amphotericin B):** This antifungal is notorious for "shake and bake" reactions (fever, chills) and nephrotoxicity, but it does not typically cause sedation. **High-Yield NEET-PG Pearls for Phenytoin:** 1. **Zero-Order Kinetics:** At therapeutic levels, phenytoin follows non-linear (saturable) elimination; a small dose increase can lead to a massive jump in plasma levels. 2. **P450 Inducer:** It is a potent hepatic enzyme inducer, decreasing the efficacy of drugs like warfarin and OCPs. 3. **Teratogenicity:** Causes **Fetal Hydantoin Syndrome** (cleft lip/palate, digital hypoplasia). 4. **Chronic Side Effects (Mnemonic: P-H-E-N-Y-T-O-I-N):** **P**roliferation of gums (Gingival hyperplasia), **H**irsutism, **E**nlarged lymph nodes, **N**ystagmus, **Y**ellow-brown skin, **T**eratogenicity, **O**steomalacia, **I**nterference with B12/Folate (Megaloblastic anemia), **N**europathy.

Question 168: Flumazenil can reverse the respiratory depression caused by which of the following agents?

A. Fentanyl
B. Ketamine
C. Midazolam (Correct Answer)
D. Propofol

Explanation: **Explanation:** **1. Why Midazolam is Correct:** Flumazenil is a competitive **benzodiazepine (BZD) receptor antagonist**. It binds specifically to the GABA-A receptor complex at the benzodiazepine binding site, effectively displacing BZDs and reversing their sedative and respiratory-depressant effects. **Midazolam** is a short-acting benzodiazepine; therefore, Flumazenil is its specific pharmacological antidote. **2. Why Other Options are Incorrect:** * **Fentanyl (Option A):** This is an opioid analgesic. Respiratory depression caused by opioids is reversed by **Naloxone** (a competitive opioid receptor antagonist), not Flumazenil. * **Ketamine (Option B):** This is a dissociative anesthetic that acts primarily as an **NMDA receptor antagonist**. It typically maintains airway reflexes and does not have a specific pharmacological reversal agent. * **Propofol (Option C):** This IV anesthetic works by enhancing GABA-A receptor activity at a site distinct from benzodiazepines. There is no specific antagonist for Propofol; management is purely supportive. **3. High-Yield Clinical Pearls for NEET-PG:** * **Half-life Caution:** Flumazenil has a very short half-life (~1 hour). Since many benzodiazepines (like Diazepam) last longer, **re-sedation** can occur, requiring repeated doses or an infusion. * **Seizure Risk:** Use Flumazenil with extreme caution in patients with chronic BZD use or tricyclic antidepressant (TCA) overdose, as it can precipitate **acute withdrawal seizures**. * **Indications:** It is used for reversing conscious sedation and in the management of suspected BZD overdose.

Question 169: In organophosphorus compound poisoning, what is the primary action of organophosphorus compounds?

A. Phosphorylate enzymes (Correct Answer)
B. Irreversibly inhibit cholinesterase
C. Oximes are effective when given beyond 24 hours
D. Atropine cannot reverse symptoms in the early stage

Explanation: **Explanation:** **Correct Option: A. Phosphorylate enzymes** Organophosphorus (OP) compounds are esters of phosphoric acid. Their primary mechanism of action is the **phosphorylation** of the serine hydroxyl group at the active site of the enzyme **Acetylcholinesterase (AChE)** [1], [3]. This leads to the inactivation of the enzyme, resulting in the massive accumulation of acetylcholine at muscarinic and nicotinic receptors, causing a "cholinergic crisis." **Analysis of Incorrect Options:** * **B. Irreversibly inhibit cholinesterase:** While OP compounds are often called "irreversible" inhibitors, the initial phosphorylation is technically **reversible**. The inhibition only becomes truly irreversible after a process called **"Aging"** (loss of an alkyl group from the phosphorylated enzyme) [3]. Until aging occurs, the enzyme can be reactivated by oximes. * **C. Oximes are effective when given beyond 24 hours:** This is incorrect because once "aging" of the enzyme-toxin complex occurs (usually within 24–48 hours for most compounds), oximes can no longer dephosphorylate the enzyme [2], [3]. Therefore, oximes must be administered early to be effective. * **D. Atropine cannot reverse symptoms in the early stage:** Atropine is the specific antidote for the muscarinic effects of OP poisoning and is highly effective in the early stages to reverse life-threatening symptoms like bradycardia and bronchoconstriction [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Atropine:** Competitive antagonist at muscarinic receptors. It does **not** reverse nicotinic effects (like muscle paralysis). * **Oximes (Pralidoxime/PAM):** These are "Cholinesterase Reactivators." They work by pulling the phosphate group off the enzyme [3]. * **Management Goal:** "Atropinization" is achieved when secretions dry up and the heart rate increases (Pupillary dilation is a late/unreliable sign). * **Diagnosis:** Suspect OP poisoning in a patient with miosis, salivation, and the characteristic "garlic odor" of breath/vomitus.

Question 170: What is the recommended treatment for salicylate poisoning?

A. Forced diuresis (Correct Answer)
B. Chelating agent
C. Atropine
D. Conservation

Explanation: **Explanation:** **1. Why Forced Diuresis is Correct:** Salicylates (Aspirin) are **weakly acidic drugs**. In salicylate poisoning, the primary goal is to enhance renal excretion. This is achieved through **Alkaline Forced Diuresis**. By administering intravenous sodium bicarbonate, the urine pH is increased. In an alkaline medium, acidic drugs like salicylate become **ionized** (polar). Since ionized drugs cannot easily cross the lipid membrane of the renal tubules, they are "trapped" in the tubular lumen and excreted. This principle is known as **Ion Trapping**. **2. Why Other Options are Incorrect:** * **B. Chelating agents:** These are used for heavy metal poisoning (e.g., EDTA for lead, Desferrioxamine for iron). Salicylates do not bind to chelators. * **C. Atropine:** This is an anticholinergic used for organophosphate poisoning or bradycardia; it has no role in managing salicylate toxicity. * **D. Conservation:** Conservative management (observation) is insufficient for salicylate poisoning due to the risk of severe metabolic acidosis, respiratory alkalosis, and potential multi-organ failure. **3. NEET-PG High-Yield Pearls:** * **Triad of Salicylate Toxicity:** Hyperventilation (respiratory alkalosis), Tinnitus (early sign), and Metabolic Acidosis. * **Treatment of Choice:** For mild-to-moderate cases, **Alkaline Diuresis** (pH 7.5–8.5). For severe cases (levels >100 mg/dL), **Hemodialysis** is the definitive treatment. * **Contraindication:** Avoid Acetazolamide; although it alkalizes urine, it causes systemic acidosis, which worsens the entry of salicylate into the brain.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free